33716687|t|Loss of Basal Forebrain Cholinergic Neurons Following Adolescent Binge Ethanol Exposure: Recovery With the Cholinesterase Inhibitor Galantamine.
33716687|a|Binge drinking and alcohol abuse are common during adolescence and cause both cognitive deficits and lasting cholinergic pathology in the adult basal forebrain. Acetylcholine is anti-inflammatory and studies using the preclinical adolescent intermittent ethanol (AIE; 5.0 g/kg, i.g., 2 day on/2 day off from postnatal day [P]25 to P54) model of human adolescent binge drinking report decreased basal forebrain cholinergic neurons (BFCNs) and induction of proinflammatory genes that persist long into adulthood. Recent studies link AIE-induced neuroimmune activation to cholinergic pathology, but the underlying mechanisms contributing to the persistent loss of BFCNs are unknown. We report that treatment with the cholinesterase inhibitor galantamine (4.0 mg/kg, i.p.) administered during AIE (i.e., P25-P54) or following the conclusion of AIE (i.e., P57-P72) recovered the persistent loss of cholinergic neuron phenotype markers (i.e., ChAT, TrkA, and p75NTR) and somal shrinkage of residual ChAT + neurons known to persist in AIE-exposed adults. Galantamine treatment also recovered the AIE-increased expression of the proinflammatory receptors TLR4 and RAGE, the endogenous TLR4/RAGE agonist HMGB1, and the transcription activation marker pNF-kappaB p65. Interestingly, we find BFCNs express TLR4 and RAGE, and that AIE treatment increased pNF-kappaB p65 expression in adult ChAT + IR neurons, consistent with intracellular HMGB1-TLR4/RAGE signaling within BFCNs. AIE increased epigenetic transcription silencing markers (i.e., H3K9me2 and H3K9me3) in the adult basal forebrain and H3K9me2 occupancy at cholinergic phenotype gene promoters (i.e., ChAT and TrkA). The finding of no AIE-induced changes in total basal forebrain NeuN + neurons with galantamine reversal of AIE-induced ChAT + neuron loss, TLR4/RAGE-pNF-kappaB p65 signals, and epigenetic transcription silencing markers suggests that AIE does not cause cell death, but rather the loss of the cholinergic phenotype. Together, these data suggest that AIE induces HMGB1-TLR4/RAGE-pNF-kappaB p65 signals, causing the loss of cholinergic phenotype (i.e., ChAT, TrkA, and p75NTR) through epigenetic histone transcription silencing that result in the loss of the BFCN phenotype that can be prevented and restored by galantamine.
33716687	71	78	Ethanol	Chemical	MESH:D000431
33716687	107	121	Cholinesterase	Gene	590
33716687	132	143	Galantamine	Chemical	MESH:D005702
33716687	145	159	Binge drinking	Disease	MESH:D063425
33716687	164	177	alcohol abuse	Disease	MESH:D000437
33716687	223	241	cognitive deficits	Disease	MESH:D003072
33716687	306	319	Acetylcholine	Chemical	MESH:D000109
33716687	328	340	inflammatory	Disease	MESH:D007249
33716687	399	406	ethanol	Chemical	MESH:D000431
33716687	490	495	human	Species	9606
33716687	507	521	binge drinking	Disease	MESH:D063425
33716687	600	615	proinflammatory	Disease	
33716687	859	873	cholinesterase	Gene	590
33716687	884	895	galantamine	Chemical	MESH:D005702
33716687	1082	1086	ChAT	Gene	1103
33716687	1088	1092	TrkA	Gene	4914
33716687	1098	1104	p75NTR	Gene	4804
33716687	1138	1142	ChAT	Gene	1103
33716687	1193	1204	Galantamine	Chemical	MESH:D005702
33716687	1266	1281	proinflammatory	Disease	
33716687	1292	1296	TLR4	Gene	7099
33716687	1301	1305	RAGE	Gene	177
33716687	1322	1326	TLR4	Gene	7099
33716687	1327	1331	RAGE	Gene	177
33716687	1340	1345	HMGB1	Gene	3146
33716687	1440	1444	TLR4	Gene	7099
33716687	1449	1453	RAGE	Gene	177
33716687	1523	1527	ChAT	Gene	1103
33716687	1572	1577	HMGB1	Gene	3146
33716687	1578	1582	TLR4	Gene	7099
33716687	1583	1587	RAGE	Gene	177
33716687	1795	1799	ChAT	Gene	1103
33716687	1804	1808	TrkA	Gene	4914
33716687	1874	1878	NeuN	Gene	146713
33716687	1894	1905	galantamine	Chemical	MESH:D005702
33716687	1930	1934	ChAT	Gene	1103
33716687	1950	1954	TLR4	Gene	7099
33716687	1955	1959	RAGE	Gene	177
33716687	2172	2177	HMGB1	Gene	3146
33716687	2178	2182	TLR4	Gene	7099
33716687	2183	2187	RAGE	Gene	177
33716687	2261	2265	ChAT	Gene	1103
33716687	2267	2271	TrkA	Gene	4914
33716687	2277	2283	p75NTR	Gene	4804
33716687	2367	2371	BFCN	Disease	
33716687	2420	2431	galantamine	Chemical	MESH:D005702
33716687	Positive_Correlation	3146	7099
33716687	Negative_Correlation	MESH:D005702	4804
33716687	Negative_Correlation	MESH:D005702	590
33716687	Negative_Correlation	MESH:D005702	4914
33716687	Positive_Correlation	MESH:D000431	MESH:D063425
33716687	Negative_Correlation	MESH:D005702	7099
33716687	Negative_Correlation	MESH:D000431	MESH:D005702
33716687	Negative_Correlation	MESH:D005702	3146
33716687	Negative_Correlation	MESH:D000109	MESH:D007249
33716687	Positive_Correlation	177	3146
33716687	Negative_Correlation	MESH:D005702	1103
33716687	Negative_Correlation	MESH:D005702	177

